Stability Testing

Stability Testing encompasses systematic evaluation of how pharmaceutical products' quality characteristics change over time under various environmental conditions including temperature, humidity, and light exposure, establishing shelf life, defining storage conditions, and supporting quality specifications. These comprehensive programmes follow ICH guidelines prescribing study designs, sampling timepoints, testing parameters, and data evaluation methods ensuring global regulatory acceptance.

The pharmaceutical industry conducts extensive stability programmes throughout development and commercial phases. Development stability supports investigational product expiry dating for clinical trials. Registration stability provides primary data supporting initial marketing applications. Post-approval stability monitors commercial batches confirming predicted behaviour throughout the product lifecycle. Testing parameters include appearance, assay measuring active content, degradation products quantifying impurities, and dissolution assessing release characteristics. For biologics, stability assessment includes aggregation, charge variants, glycosylation changes, potency through bioassays, and visual inspection for particulates. Statistical analysis evaluates trends determining expiry dating. Accelerated conditions predict shelf life using Arrhenius relationships. Photostability testing evaluates light sensitivity, informing packaging and handling. Regulatory requirements mandate stability data in applications. As products become increasingly complex and packaging innovations emerge, stability science continues advancing through improved analytical methods, predictive modelling, and innovative storage solutions ensuring product quality throughout distribution.